May 20th, 2012
AN INCREASING number of Australian children are receiving treatment at a special clinic for gender identity disorder, including hormone treatments to make them feel more like the opposite sex.
Since 2003, a publicly funded clinic at Melbourne’s Royal Children’s Hospital has treated 39 children and adolescents for gender identity disorder – a condition where a person feels trapped within a body of the opposite sex.
Seven of these children successfully applied to the Family Court to suppress puberty so they had more time to consider sex-change treatments in late adolescence or adulthood. Others have court applications pending, while some could not afford the legal costs or wanted to continue counselling.
All seven adolescents who had puberty suppressed went on to receive cross-sex hormone treatments at age 15 or 16 so they felt more like the sex they identified with. Surgery is only available to people over 18.
For biological males, oestrogen treatment encourages breasts and other female characteristics while softening testicles and making them smaller. For females, testosterone suppresses menstruation and encourages hair growth, muscle bulk and voice deepening, with the latter being irreversible. It also increases the size of the clitoris and increases erections.
Negative side effects of the cross-sex hormones are rare but can include migraines and liver problems. The long-term rate of regret with reversal of gender identity for adolescents is unknown, but researchers say less than 1 per cent of adults who have sex change surgery after thorough assessment regret their decision.
Writing in the Medical Journal of Australia, the doctors who run the clinic, Jacqueline Hewitt and Paul Campbell, said all patients received mental health assessments and support, and in cases of unrelenting cross-gender thought and behaviour, hormone treatments were considered. They said puberty could exacerbate distress for children with some expressing revulsion towards parts of their bodies and becoming suicidal.
Growing awareness of the service meant patient referrals had increased from one in 2003 to eight last year and they said the clinic had become the main service for children and adolescents across Australia having hormone treatments. ”We’d like to see clinics in other major cities,” said Dr Campbell, a psychiatrist and director of the clinic. ”It’s important to provide the right support and access to experience.”
A Victorian mother whose biological son attended the clinic at age seven said she felt immense relief to find specialist help for her child, who is now having hormone treatment to suppress puberty. She said that from about 2½ years old, her son behaved like a girl and told her he was a girl.
Her child received many sessions with a psychiatrist before starting to identify as a girl before the age of 12.
”All up, it took about two years for our daughter to make what is called a full social transition, but for her, it was an absolute affirmation,” the mother said.
Posted in Information | No Comments »
May 20th, 2012
PHILADELPHIA — Philadelphia Phillies general manager Ruben Amaro defended the club’s treatment of Ryan Howard in response to a newspaper report that questioned the use of cortisone on the star slugger last season.
The Phillies treated an injury to Howard’s left foot last Sept. 18 with a cortisone shot, an ailment the club termed as bursitis. Less than three weeks later, Howard tore his left Achilles tendon while running to first base after his final at-bat of the season.
That injury has kept the three-time All-Star and former MVP, who signed a five-year, $125 million extension in 2010, out all season.
“I wanted to clear up some of the insinuations regarding a cortisone shot,” Amaro said Sunday during Philadelphia’s game against Boston. “The cortisone shot was treated for some [other] issue he had. It was not part of the Achilles injury. We didn’t feel it was an issue. That was resolved by the time he had his injury. One thing had nothing to do with the other.”
Amaro was responding to a story in Sunday’s Philadelphia Inquirer suggesting the cortisone shot may have contributed to the Achilles injury.
A doctor in the Inquirer report was quoted as saying, “When it comes to the risk of an Achilles tendon tear, I’m concerned about cortisone.”
Amaro said the Phillies always put their players first.
“We’re probably one of the most conservative clubs in baseball in administering treatment, and we always want to make sure we have the player’s best interest,” Amaro said.
Posted in Information | No Comments »
May 18th, 2012
03/15/12 – Autism Advisory Task Force – Slide Presentation: Autism Treatment Mandates in the US – Part 3 of 7
Posted in Videos | No Comments »
May 18th, 2012
The R.C. Harris Water Treatment Plant began operating in Toronto's east end in 1941. It's the largest water treatment plant in the city, producing 36 per cent (166,500,000,000 litres) of Toronto's water in 2011. The building offers a distinct architectural statement with its art deco styling, and was declared a national historic civil engineering site in 1992. A rehabilitation of the plant is …
Posted in Information | No Comments »
May 18th, 2012
REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND–(Marketwire -05/18/12)-
Kerecis, the emerging tissue-regeneration company, has successfully completed a 37-patient follow-up study of its MariGen Wound treatment product for chronic wounds.
MariGen Wound is a fish-skin-derived, extra-cellular matrix that contains Omega3 and intact proteins from fish skin. The product is manufactured according to a patent-pending method where all allergenic materials are removed. When used, MariGen is applied to the wound bed where it acts as a scaffold that is populated by the body’s own cells. Ultimately the product is converted into functional living tissue. MariGen is suitable for the treatment of chronic wounds, including diabetic, vascular and other hard-to-heal wounds.
The 37 patients in the study had chronic wounds that had not responded to conventional treatment. Some of the wounds had even deteriorated under such treatment. On the other hand, more than 90% of the wounds treated with MariGen Wound improved after four weeks and none got worse. No adverse effects, including allergies, were reported either clinically or in serology analysis.
Statistics show a large unmet need for wound care. Each year about 6 million Americans suffer from problem wounds caused by diabetes, circulatory problems and other conditions, with 1.1 to 1.8 million new cases added each year.
More than 20 million Americans have diabetes, almost 20 percent of whom are over the age of 60. A full 15 percent of all diabetics will develop problem wounds, and about 82,000 diabetics undergo amputation each year because of such wounds.
Comments:
Dr. Baldur Tumi Baldursson (PhD) (MD), Kerecis Medical Director:
“In the study we monitored 37 patients for up to one year after treatment with MariGen Wound both for clinical results and for immunological effects. Thirty-six of the wounds (97 percent) improved with treatment. The 37th wound did not improve but also did not get worse, and no immunological effects were recorded.”
Dr. Hilmar Kjartansson (MD), Kerecis Director for Clinical R&D:
“The study’s results indicate that the MariGen Omega3 Extra Cellular Matrix is free from allergens and other molecules that can potentially have immunological effects on the body. Those results are important for us as we move forward to develop matrices for other indications such as meshes for hernia surgery.”
About Kerecis
Kerecis (http://www.kerecis.com) is a development and manufacturing business producing a novel, patent-pending, tissue-regeneration material derived from fish skin to accelerate the healing of wounds and tissue reconstruction. The Kerecis material addresses the large unmet need of the double-digit growth biologics segment of the chronic-wounds, hernia-repair and dermatology markets. The material offers advantages over existing human- and porcine-derived products, including improved manufacturing economics and a lower risk of disease transfer. Since it is derived from fish, the material is both kosher and halal compatible, eliminating cultural and religious constraints on usage, with equivalent or better clinical performance. For more information, e-mail info@kerecis.com or call 703-879-6535 (U.S.) or 354-8494960 (Iceland).
Posted in Information | No Comments »
May 16th, 2012
Even at 80 or Older, Age Shouldn’t Be a Barrier to Surgery for ‘C2′ Fractures
Newswise — Philadelphia, Pa. (May 16, 2012) – For older adults with “C2″ fractures of the upper (cervical) spine, surgery and nonsurgical treatment provide similar short- and long-term outcomes, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Although the patients were at significant risk of complications and death in the year or two after C2 fracture, these risks are similar with surgical and nonsurgical treatment. “[T]hus, age alone does not appear to be a contraindication to surgical fixation of C2 fractures,” concludes the study by Dr. Maxwell Boakye of University of Louisville, KY, and colleagues.
Surgery vs Immobilization for C2 Fractures The researchers analyzed the outcomes of 56 older adults—average age 80 years—treated for fractures of the second cervical vertebra, or “atlas,” over a ten-year period. Older adults are at increased risk of C2 fractures, a serious injury that requires prompt treatment to prevent injury to the cervical (neck) portion of the spinal cord. None of the patients had evidence of spinal cord damage at the time they were treated.
Options for treatment for C2 fractures are surgery to stabilize the fracture or nonsurgical treatment (immobilization) to allow the fracture to heal. In the study, 28 patients were treated with surgery and 28 with immobilization. (The treatments weren’t randomly assigned, but were up to the choice of the treating physician.) Dr. Boakye and colleagues compared the short- and long-term outcomes of the surgical and nonsurgical treatment groups.
The two groups were similar in terms of age and other characteristics. Most had two or more accompanying (comorbid) medical problems. The fracture fragments were more displaced (four versus one millimeters)—indicating somewhat more severe fractures—for patients undergoing surgery.
Surgery generally consisted of an operation to fuse the fractured C2 vertebra to one or more adjoining vertebra. Nonsurgical treatment consisted of several weeks of immobilization, usually in a hard cervical collar. The surgical patients spent more time in the hospital—averaging about twelve versus four days—but both groups had good fracture healing. None of the patients in the nonsurgical group required later surgery
Both groups of elderly patients with C2 fractures had significant but similar rates of death and complications. Within 30 days, one patient died in the surgical group and two in the nonsurgical group. Complication rates were 18 versus 25 percent.
Age Is No Barrier to Surgery Especially with the aging of the population, there’s a need for information on the outcomes of surgical versus nonsurgical treatment for elderly patients with C2 fractures. Some previous studies have suggested increased rates of death or complications, including failed fracture healing, in older adults receiving nonsurgical treatment for C2 fractures.
Although not a formal randomized trial, the new study suggests similar outcomes of the two approaches to treatment for C2 fractures in older adults. “The data…demonstrate equivalent complications and mortality, where both groups were of similar age and overall health,” the researchers add.
There was also no evidence that younger, healthier patients were more likely to undergo surgery. Dr. Boakye and coauthors conclude, “Surgery should not be excluded as an intervention if the physician believes it to be the better treatment option, especially for unstable fractures.” They emphasize the need for further studies, including cost-effectiveness comparisons of surgical versus nonsurgical treatment for stable C2 fractures.
###
About Neurosurgery Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.
About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes. LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).
Comment/Share
Posted in Information | No Comments »
May 16th, 2012
![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif)
Public release date: 16-May-2012
[
| E-mail
| Share
]
Contact: Connie Hughes Connie.Hughes@wolterskluwer.com
646-674-6348 Wolters Kluwer Health
Even at 80 or older, age shouldn’t be a barrier to surgery for ‘C2′ fractures
Philadelphia, Pa. (May 16, 2012) For older adults with “C2″ fractures of the upper (cervical) spine, surgery and nonsurgical treatment provide similar short- and long-term outcomes, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Although the patients were at significant risk of complications and death in the year or two after C2 fracture, these risks are similar with surgical and nonsurgical treatment. “[T]hus, age alone does not appear to be a contraindication to surgical fixation of C2 fractures,” concludes the study by Dr. Maxwell Boakye of University of Louisville, KY, and colleagues.
Surgery vs Immobilization for C2 Fractures
The researchers analyzed the outcomes of 56 older adultsaverage age 80 yearstreated for fractures of the second cervical vertebra, or “atlas,” over a ten-year period. Older adults are at increased risk of C2 fractures, a serious injury that requires prompt treatment to prevent injury to the cervical (neck) portion of the spinal cord. None of the patients had evidence of spinal cord damage at the time they were treated.
Options for treatment for C2 fractures are surgery to stabilize the fracture or nonsurgical treatment (immobilization) to allow the fracture to heal. In the study, 28 patients were treated with surgery and 28 with immobilization. (The treatments weren’t randomly assigned, but were up to the choice of the treating physician.) Dr. Boakye and colleagues compared the short- and long-term outcomes of the surgical and nonsurgical treatment groups.
The two groups were similar in terms of age and other characteristics. Most had two or more accompanying (comorbid) medical problems. The fracture fragments were more displaced (four versus one millimeters)indicating somewhat more severe fracturesfor patients undergoing surgery.
Surgery generally consisted of an operation to fuse the fractured C2 vertebra to one or more adjoining vertebra. Nonsurgical treatment consisted of several weeks of immobilization, usually in a hard cervical collar. The surgical patients spent more time in the hospitalaveraging about twelve versus four daysbut both groups had good fracture healing. None of the patients in the nonsurgical group required later surgery
Both groups of elderly patients with C2 fractures had significant but similar rates of death and complications. Within 30 days, one patient died in the surgical group and two in the nonsurgical group. Complication rates were 18 versus 25 percent.
Age Is No Barrier to Surgery
Especially with the aging of the population, there’s a need for information on the outcomes of surgical versus nonsurgical treatment for elderly patients with C2 fractures. Some previous studies have suggested increased rates of death or complications, including failed fracture healing, in older adults receiving nonsurgical treatment for C2 fractures.
Although not a formal randomized trial, the new study suggests similar outcomes of the two approaches to treatment for C2 fractures in older adults. “The datademonstrate equivalent complications and mortality, where both groups were of similar age and overall health,” the researchers add.
There was also no evidence that younger, healthier patients were more likely to undergo surgery. Dr. Boakye and coauthors conclude, “Surgery should not be excluded as an intervention if the physician believes it to be the better treatment option, especially for unstable fractures.” They emphasize the need for further studies, including cost-effectiveness comparisons of surgical versus nonsurgical treatment for stable C2 fractures.
About Neurosurgery
Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world’s most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.
About Lippincott Williams & Wilkins
Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes. LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of 3.4 billion ($4.7 billion).
[
| E-mail
| Share
]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Posted in Information | No Comments »
May 14th, 2012
NEW YORK (AP) — Shares of Ventrus Biosciences Inc. jumped Monday after the company said a late-stage study shows its diltiazem cream is more effective than a placebo as a treatment for anal fissures.
The cream is designed to treat pain caused by anal fissures, which are tears in the lining of the anal canal. Those tears can cause severe pain. Ventrus said two strengths of diltiazem were more effective than a placebo in treating patients’ pain associated with defecation. Both strengths were also more effective than placebo in terms of overall pain and healing.
Shares of Ventrus climbed $2.11, or 19.3 percent, to $13.07 in midday trading.
Ventrus said the cream was applied three times per day for eight weeks, and patients were then observed for four weeks after the end of treatment. A total of 465 patients were involved in the trial. The company said the side effects of diltiazem and placebo were similar. The most common types of side effects were gastrointestinal disorders.
Diltiazem has long been used in pill form as a treatment for high blood pressure and angina. It is the active ingredient in drugs including Cardizem.
Ventrus has the rights to market diltiazem cream in the U.S. and is developing the drug with SLA Pharma.
Posted in Information | No Comments »
May 14th, 2012
DENVER, May 14, 2012 /PRNewswire/ – The Academy of Eating Disorders awarded the 2012 Outstanding Clinician Award to Philip S. Mehler, MD, FACP, FAED, CEDS, a Denver-based internal medicine doctor specializing in treatment for the medical complications of eating disorders. The award provides international recognition for a lifetime of service and outstanding clinical contributions to the field.
Dr. Mehler has dedicated the past 25 years of his career to the research and medical care of patients suffering from the most severe eating disorders. In a field where mental health care and therapeutic intervention is the focus, Dr. Mehler’s contributions to diagnosis and treatment of medical complications have been invaluable. In 2009, he founded the ACUTE Center for Eating Disorders at Denver Health, the nation’s only specialized medical stabilization unit for the most severe eating disorders where he continues to conduct research and provide life-saving treatment.
Dr. Mehler is Founder and Medical Director of the ACUTE Center for Eating Disorders at Denver Health, Glassman Professor of Medicine at the University of Colorado School of Medicine, and Chief Medical Officer of Denver Health Medical Center. He has authored over 300 publications including the textbook, Eating Disorders: A Guide to Medical Care and Complications, and multiple articles on the medical complications of eating disorders. Dr. Mehler is a member and Fellow of the Academy of Eating Disorders as well as the Eating Disorders Research Society. He has lectured extensively on a national and international level on the topic. Dr. Mehler has been recognized as one of the “Best Doctors in America” for 13 years and multiple times by 5280 Magazine as “Top Internist in Denver.”
About ACUTE Center for Eating Disorders at Denver Health
The ACUTE Center for Eating Disorders offers comprehensive stabilization and expert care for the most medically compromised eating disorder patients. Patients are offered the very best in medical treatment, a compassionate and experienced nursing staff, individual psychotherapy and thorough discharge planning to help them on their path to recovery. The ACUTE Center is tailored to help both males & females who cannot seek care in a traditional inpatient or residential treatment setting due to the severity of their weight loss or other medical complications.
About Denver Health
Denver Health is the Rocky Mountain Region’s Level I academic trauma center, and the safety net hospital for the Denver area. The Denver Health system, which integrates acute and emergency care with public and community health, includes the Rocky Mountain Regional Trauma Center, Denver’s 911 emergency medical response system, Denver Health Paramedic Division, eight family health centers, 14 school-based health centers, the Rocky Mountain Poison and Drug Center, NurseLine, Denver CARES, Denver Public Health, ACUTE Center for Eating Disorders, the Denver Health Foundation and the Rocky Mountain Center for Medical Response to Terrorism, Mass Casualties and Epidemics.
About AED
The Academy for Eating Disorders is a global and trans-disciplinary professional organization with more than 1,500 members from 47 countries worldwide. AED provides educational resources and platforms for professional dialogue, training, and collaboration through its publications, including the International Journal of Eating Disorders, annual International Conferences on Eating Disorders, clinical teaching days and other programs.
Contact: Rachael Harriman, rachael.harriman@dhha.org, 303-602-5550
Posted in Information | No Comments »
May 12th, 2012
MORE INFO HERE CHECK ME OUT!!!!!! MY BLOG-naturallyahsiek.blogspot.com MY FACEBOOK-www.facebook.com MY Tumblr-ahsiek1118.tumblr.com Twitter-twitter.com Instagram (AHSIEK1118) Check Out This Awesome Tutorial I Did For Mane Moves TV Scarves as Hair Accessories with Ahsiek1118 www.youtube.com CHECK OUT MY HOT OIL HONEY TREATMENT www.youtube.com SEND YOUR PIC OF YOU DOING *FACE* Leave Your Name Also..:) ahsiek1118@hotmail.com For more info and to purchase any of the products head over to the links following www.etsy.com www.facebook.com Ingredients Purified water,Rhassoul,Raw honey,Organic cocoa powder,Unrefined cocoa butter,Organic aloe vera,Extra virgin olive oil,Slippery elm,Guar, emulsifier,essential oils
Posted in Videos | No Comments »
|
|